Common Contracts
2 similar Collaboration Agreement contracts by iTeos Therapeutics, Inc.
THIRD AMENDED AND RESTATED COLLABORATION AGREEMENTCollaboration Agreement • May 13th, 2021 • iTeos Therapeutics, Inc. • Biological products, (no disgnostic substances) • Delaware
This Third Amended and Restated Collaboration Agreement (the “Agreement”) is made effective as of February 22, 2021 (the “Third A&R Effective Date”), by and between Adimab, LLC, a Delaware limited liability company having an address at 7 Lucent Drive, Lebanon, NH 03766 (“Adimab”), and iTeos Belgium S.A., having its registered offices at Rue des Freres Wright, 29, B-6041 Gosselies Belgium (“iTeos”). This Agreement amends and restates the Second Amended and Restated Collaboration Agreement dated July 23, 2018, as amended, between the Parties.
CERTAIN CONFIDENTIAL PORTIONS OF THIS EXHIBIT HAVE BEEN OMITTED AND REPLACED WITH “[***]”. SUCH IDENTIFIED INFORMATION HAS BEEN EXCLUDED FROM THIS EXHIBIT BECAUSE IT IS (I) NOT MATERIAL AND (II) WOULD LIKELY CAUSE COMPETITIVE HARM TO THE COMPANY IF...Collaboration Agreement • June 24th, 2020 • iTeos Therapeutics, Inc. • Biological products, (no disgnostic substances) • Delaware
THIS SECOND AMENDED AND RESTATED COLLABORATION AGREEMENT (the “Agreement”) is made effective as of July 23, 2018 (the “Effective Date”), by and between Adimab, LLC, a Delaware limited liability company having an address at 7 Lucent Drive, Lebanon, NH 03766 (“Adimab”), and iTeos Therapeutics S.A., having its registered offices at Rue des Frères Wright, 29 B-6041 Gosse1ies Belgium (“iTeos”). This Agreement amends and restates the Amended and Restated Collaboration Agreement dated January 23, 2017, as amended, between the Parties.
